ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 014

Characterizing Lupus in African American Children in Southern United States

Anita Dhanrajani1, Taylor Long1, Spencer Hagwood2, Leslie Johnson1 and Cynthia Karlson1, 1University of Mississipi Medical Center, Jackson, MS, 2University of Mississipi Medical Center School of Medicine, Jackson, MS

Meeting: 2023 Pediatric Rheumatology Symposium

Keywords: Access to care, Disparities, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Thursday, March 30, 2023

Title: Poster Breakout 1 - Lupus: Genetics, Epigenetics, & Social Determinants

Session Type: Breakout Session

Session Time: 5:10PM-5:40PM

Background/Purpose: African-American (AA) ethnicity is a known predisposing factor for childhood onset systemic lupus erythematosus (cSLE) and a predictor of poor outcomes. In addition to race/ethnicity, income and geographical location are known drivers of health care disparities in cSLE. Despite this knowledge, there is lack of literature describing demographic and clinical features of cSLE in a predominantAA cohort. This study aims to characterize demographic and clinical features of cSLE patients in the Southeast United States compared to current literature describing predominantly Caucasian cohorts. The results from this studywill drive future work in comparing outcomes in cSLE and uncovering factors leading to disparities in other regions of the United States.

Methods: This is a cross sectional study of cSLE patients from 2 centers in Southeast United States – University of Mississippi Medical center (UMMC) and University of Alabama at Birmingham (UAB). Prevalent and incident patients with cSLE at UMMC were enrolled after obtaining consent. Demographic, social and clinical data was retrospectively collected by review of the medical charts. Similar data was obtained for the UAB cohort for patients with cSLE via the CARRA registry database. The data from both cohorts was combined and analyzed using SPSS statistical software. Descriptive statistics were used for demographic and clinical features. Unpaired t test and chi square test were used to compare outcomes in this cohort with those reported in the literature.

Results: Results are described for a total cohort of 36 patients, comprising 17 from UMMC and 19 from UAB. 31/36 (86.11%) were female, 28/36 (77.78%) were of AA ethnicity, and 23/36 (64%) had Medicaid insurance. Mean age at diagnosis (+/- SD) of SLE for the cohort was 13.7 years (+/- 2.9). Mean ACR score at diagnosis was 5.2 (+/- 1.29), SLICC score was 8.8 (+/- 2.2). Average baseline SLEDAI was 12.14 (+/- 9.6), SLEDAI at 6 months and 1 year respectively was 6.84 and 3.95. Average distance traveled to see a rheumatologist was 74.72 miles compared to a national average of 42.8 miles. 30/36 patients (83.33%) belonged to medium-high or high Social Vulnerability Index group based on zip code. Twenty five percent of patients had some renal involvement. Average SLEDAI compared to a multiethnic Canadian cohort with 10% black population, was significantly higher: 12.14 versus 3.1 (p < 0.00001). 15/36 had SDI > 0 (46.66%) versus 16% reported in the literature (p < 0.0001). 12/36 (33.3%) had SDI >/= 2 compared to 7% reported in the literature (p < 0.0001).

Conclusion: This study described the clinical and socioeconomic characteristics of a predominately AA cSLE population from 2 centers in the Southeastern United States. Compared to multiethnic cohorts of cSLE from Canada, this patient population has significantly higher disease activity and greater damage accrual. Social risk factors for this population include a higher social vulnerability index, longer distance from an academic pediatric rheumatology center, and having Medicaid insurance. The effect of these factors on disparity of disease outcomes needs to be further explored with larger cohorts.

Supporting image 1

Supporting image 2


Disclosures: A. Dhanrajani: None; T. Long: None; S. Hagwood: None; L. Johnson: None; C. Karlson: None.

To cite this abstract in AMA style:

Dhanrajani A, Long T, Hagwood S, Johnson L, Karlson C. Characterizing Lupus in African American Children in Southern United States [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 4). https://acrabstracts.org/abstract/characterizing-lupus-in-african-american-children-in-southern-united-states/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2023 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characterizing-lupus-in-african-american-children-in-southern-united-states/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology